-
1Academic Journal
Συγγραφείς: S. V. Zhuravel, P. Yu. Falevko, V. A. Manukovskiy, M. E. Malyshev, С. В. Журавель, П. Ю. Фалевко, В. А. Мануковский, М. Е. Малышев
Πηγή: Transplantologiya. The Russian Journal of Transplantation; Том 17, № 2 (2025); 200-214 ; Трансплантология; Том 17, № 2 (2025); 200-214 ; 2542-0909 ; 2074-0506
Θεματικοί όροι: заместительная почечная терапия, orthotopic liver transplantation, renal replacement therapy, ортотопическая трансплантация печени
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/1008/946; https://www.jtransplantologiya.ru/jour/article/view/1008/952; Battistella S, Grasso M, Catanzaro E, D'Arcangelo F, Corrà G, Germani G, et al. Evolution of liver transplantation indications: expanding horizons. Medicina (Kaunas). 2024;60(3):412. PMID: 38541138 htpps://doi.org/10.3390/medicina60030412; Häberle J, Siri B, Dionisi-Vici C. Quo vadis ureagenesis disorders? A journey from 90 years ago into the future. J Inherit Metab Dis. 2024;47(6):1120-1128. PMID: 38837457 https://doi.org/10.1002/jimd.12763; Krutsinger D, Pezzulo A, Blevins AE, Reed RM, Voigt MD, Eberlein M. Idiopathic hyperammonemia after solid organ transplantation: primarily a lung problem? A single-center experience and systematic review. Clin Transplant. 2017;31(5):e12957. PMID: 28295601 https://doi.org/10.1111/ctr.12957; Lichtenstein GR, Yang YX, Nunes FA, Lewis JD, Tuchman M, Tino G, et al. Fatal hyperammonemia after orthotopic lung transplantation. Ann Int Med. 2000;132(4):283–287. PMID: 10681283 https://doi.org/10.7326/0003-4819-132-4-200002150-00006; Catherine Ch, Bain KB, Iuppa JA, Yusen RD, Byers DE, Patterson GA, et al. Hyperammonemia syndrome after lung transplantation: a single center experience. Transplantation. 2016;100(3):678– 684. PMID: 26335916 https://doi.org/10.1097/TP.0000000000000868; Seethapathy H, Fenves AZ. Pathophysiology and management of hyperammonemia in organ transplant patients. Am J Kidney Dis. 2019;74(3):390–398. PMID: 31040091 https://doi.org/10.1053/j.agkd.2019.03.419; Plöchl W, Plöchl E, Pokorny H, Kozek-Langenecker S, Zacherl J, Stöckler-Ipsiroglu S, et al. Multiorgan donation from a donor with unrecognized ornithine transcarbamylase deficiency. Transplant Int. 2001;14(3):196-201. PMID: 11499911 https://doi.org/10.1007/s001479900134; Jalan R, De Chiara F, Balasubramaniyan V, Andreola F, Khetan V, Malago M, et al. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. J Hepatol. 2016;64(4):823–833. PMID: 26654994 https://doi.org/10.1016/j.jhep.2015.11.019; Zhou Y, Eid T, Hassel B, Danbolt NC. Novel aspects of glutamine synthetase in ammonia homeostasis. Neurochem Int. 2020;140:104809. PMID: 32758585 https://doi.org/10.1016/j.neuint.2020.104809; Adeva MM, Souto G, Blanco N, Donapetry C. Ammonium metabolism in humans. Metabolism. 2012;61(11):1495– 1511. PMID: 22921946 https://doi.org/10.1016/j.metabol.2012.07.007; Olde Damink SW, Jalan R, Dejong CH. Interorgan ammonia trafficking in liver disease. Metab Brain Dis. 2009;24(1):169– 181. PMID: 19067143 https://doi.org/10.1007/s11011-008-9122-5; Long MT, Coursin DB. Undifferentiated non-hepatic hyperammonemia in the ICU: Diagnosis and management. J Crit Care. 2022;70:154042. PMID: 35447602 https://doi.org/10.1016/j.jcrc.2022.154042; Weiner ID, Verlander JW. Renal ammonia metabolism and transport. Compr Physiol. 2013;3(1):201–220. PMID: 23720285 https://doi.org/10.1002/cphy.c120010; Bourgeois S, Houillier P. State of knowledge on ammonia handling by the kidney. Pflugers Arch. 2024;476(4):517– 531. PMID: 38448728 https://doi.org/10.1007/s00424-024-02940-1; La M, Reid JJ. Endothelin-1 and the regulation of vascular tone. Clin Exp Pharmacol Physiol. 1995;22(5):315– 323. PMID: 7554421 https://doi.org/10.1111/j.1440-1681.1995.tb02008.x; Ghabril M, Nguyen J, Kramer D, Genco T, Mai M, Rosser BG. Presentation of an acquired urea cycle disorder post liver transplantation. Liver Transpl. 2007;13(12):1714-1716. PMID: 18044746 https://doi.org/10.1002/lt.21291; Ali R, Nagalli S. Hyperammonemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. PMID: 32491436; Chen H, Yang C, Yan S, Liu X, Zhou L, Yuan X. Sarcopenia in cirrhosis: from pathophysiology to interventional therapy. Exp Gerontol. 2024;196:112571. PMID: 39236869 https://doi.org/10.1016/j.exger.2024.112571; Weber ML, Ibrahim HN, Lake JR. Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl. 2012;18(11):1290– 1301. PMID: 22847917 https://doi.org/10.1002/lt.23522; Hussaini T, Yoshida EM, Partovi N, Erb SR, Scudamore C, Chung S, et al. Early persistent progressive acute kidney injury and graft failure post liver transplantation. Transplant Direct. 2019;5(3):e429. PMID: 30882034 https://doi.org/10.1097/TXD.0000000000000868; Barritt AS 4th, Fried MW, Hayashi PH. Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy. Dig Dis Sci. 2010;55(6):1794–1798. PMID: 19655248 https://doi.org/10.1007/s10620-009-0901-6; Mori DN, Kreisel D, Fullerton JN, Gilroy DW, Goldstein DR. Inflammatory triggers of acute rejection of organ allografts. Immunol Rev. 2014;258(1):132–144. PMID: 24517430 https://doi.org/10.1111/imr.12146; Vicente H-R, Agusti A, Cabrera-Pastor A, Fustero S, Delgado O, Taoro-Gonzalez L, et al. Sildenafil reduces neuroinflammation and restores spatial learning in rats with hepatic encephalopathy: underlying mechanisms. J Neuroinflammation. 2015;12:195. PMID: 26511444 https://doi.org/10.1186/s12974-015-0420-7; Taoro-Gonzalez L, Arenas YM, Cabrera-Pastor A, Felipo V. Hyperammonemia alters membrane expression of GluA1 and GluA2 subunits of AMPA receptors in hippocampus by enhancing activation of the IL-1 receptor: underlying mechanisms. J Neuroinflammation. 2018;15(1):36. PMID: 29422059 https://doi.org/10.1186/s12974-018-1082-z; Pun CK, Huang HC, Chang CC, Hsu SJ, Huang YH, Hou MC, et al. Hepatic encephalopathy: from novel pathogenesis mechanism to emerging treatments. J Chin Med Assoc. 2024;87(3):245–251. PMID: 38109364 https://doi.org/10.1097/JCMA.0000000000001041; Phillips SM, Pouch SM, Lo DJ, Kandiah S, Lomashvili KA, Subramanian RA, et al. A case of “cryptammonia”: disseminated cryptococcal infection generating profound hyperammonemia in a liver transplant recipient. J Investig Med High Impact Case Rep. 2022;10:23247096221129467. PMID: 36214295 https://doi.org/10.1177/23247096221129467; Baker RP, Schachter M, Phillips S, Kandiah S, Farrque M, Casadevall A, et al. Host and fungal factors both contribute to cryptococcosis-associated hyperammonemia (cryptammonia). Microbiol Spectr. 2024;12(7):e0390223. PMID: 38842310 https://doi.org/10.1128/spectrum.03902-23; Kolopaking MS. Urease, gastric bacteria and gastritis. Acta Med Indones. 2022;54(1):1–2. PMID: 35398819; Mouat S, Bishop J, Glamuzina E, Chin S, Best EJ, Evans HM. Fatal hyperammonemia associated with disseminated Serratia marcescens infection in a pediatric liver transplant recipient. Pediatr Transplantation. 2018;22(4):e13180. PMID: 29624817 https://doi.org/10.1111/petr.13180; Duarte T, Fidalgo P, Karvellas CJ, Cardoso FS. What every Intensivist should know about . Ammonia in liver failure. J Crit Care. 2024;81:154456. PMID: 37945461 https://doi.org/10.1016/j.jcrc.2023.154456; Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, et al. Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73(6):1526–1547. PMID: 33097308 https://doi.org/10.1016/j.jhep.2020.07.013; Deutsch-Link S, Moon AM, Jiang Y, Barritt AS 4th, Tapper EB. Serum ammonia in cirrhosis: clinical impact of hyperammonemia, utility of testing, and national testing trends. Clin Ther. 2022;44(3):e45–e57. PMID: 35125217 https://doi.org/10.1016/j.clinthera.2022.01.008; Лазебник Л.Б., Голованова Е.В., Алексеенко С.А., Буеверов А.О., Плотникова Е.Ю., Долгушина А.И. и др. Российский консенсус «Гипераммониемии у взрослых» (Версия 2021). Экспериментальная и клиническая гастроэнтерология. 2021;(3):97–118. https://doi.org/10.31146/1682-8658-ecg-187-3-97-118; Gupta S, Fenves AZ, Hootkins R. The role of RRT in hyperammonemic patients. Clin J Am Soc Nephrol. 2016;11(10):1872–1878. PMID: 27197910 https://doi.org/10.2215/CJN.01320216; Bernal W, Lee WM, Wendon J, Larsen FS, Williams R. Acute liver failure: a curable disease by 2024? J Hepatol. 2015;62(1 Suppl):S112–120. PMID: 25920080 https://doi.org/10.1016/j.jhep.2014.12.016; Butterworth RF. Ammonia removal by metabolic scavengers for the prevention and treatment of hepatic encephalopathy in cirrhosis. Drugs RD. 2021;21(2):123–132. PMID: 33890246 https://doi.org/10.1007/s40268-021-00345-4; Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;5(5):CD001939. PMID: 28518283 https://doi.org/10.1002/14651858.CD001939.pub4; Jalan R, O Damink SW, Deutz NE, Lee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet. 1999;354(9185):1164–1168. PMID: 10513710 https://doi.org/10.1016/s0140-6736(98)12440-6; Bosoi CR, Parent-Robitaille C, Anderson K, Tremblay M, Rose CF. AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct-ligated rats. Hepatology. 2011;53(6):1995–2002. PMID: 21384402 https://doi.org/10.1002/ hep.24273; Agarwal B, Cañizares RB, Saliba F, Ballester MP, Tomescu DR, Martin D, et al. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on-chronic liver failure. J Hepatol. 2023;79(1):79–92. PMID: 37268222 https://doi.org/10.1016/j.jhep.2023.03.013; Kurtz CB, Millet YA, Puurunen MK, Perreault M, Charbonneau MR, Isabella VM, et al. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci Transl Med. 2019;11(475):eaau7975. PMID: 30651324 https://doi.org/10.1126/scitranslmed.aau7975; Song G, Kerbet A, Jones H, Arias N, Davies N, Andreola F, et al. PS-149-recombinant glutamine synthetase: a novel strategy for the treatment of hyperammonemia and consequent hepatic encephalopathy in rodent model of cirrhosis and urea cycle enzyme deficiency. J Hepatol. 2019;70(1):e93–e94. https://doi.org/10.1016/S0618-8278(19)30167-7; Lévesque R, Leblanc M, Cardinal J, Teitlebaum J, Skrobik Y, Lebrun M. Haemodialysis for severe hyperammonaemic coma complicating urinary diversions. Nephrol Dial Transplant. 1999;14(2):458–461. PMID: 10069214 https://doi.org/10.1093/ndt/14.2.458; Naorungroj T, Yanase F, Eastwood GM, Baldwin I, Bellomo R. Extracorporeal ammonia clearance for hyperammonemia in critically Ill patients: a scoping review. Blood Purif. 2021;50(4-5):453–461. PMID: 33279903 https://doi.org/10.1159/000512100; Slack AJ, Auzinger G, Willars C, Dew T, Musto R, Corsilli D, et al. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int. 2014;34(1):42–48. PMID: 23786538 https://doi.org/10.1111/liv.12221; Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Pre-dilution vs. post-dilution during continuous venovenous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract. 2003;94(4):c94–98. PMID: 12972719 https://doi.org/10.1159/000072492; Fisher C, Baldwin I, Fealy N, Naorungroj T, Bellomo R. Ammonia clearance with different continuous renal replacement therapy techniques in patients with liver failure. Blood Purif. 2022;51(10):840–846. PMID: 35042216 https://doi.org/10.1159/000521312; Dong V, Karvellas CJ. Liver assistive devices in acute liver failure: current use and future directions. Best Pract Res Clin Gastroenterol. 2024;73:101964. PMID: 39709218 https://doi.org/10.1016/j.bpg.2024.101964; Krisper P, Haditsch B, Stauber R, Jung A, Stadlbauer V, Trauner M, et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol. 2005;43(3):451–7. PMID: 16023249 https://doi.org/10.1016/j.jhep.2005.02.038; MacDonald AJ, Karvellas CJ. Emerging role of extracorporeal support in acute and acute-on-chronic liver failure: recent developments. Semin Respir Crit Care Med. 2018;39(5):625– 634. PMID: 30485892 https://doi.org/10.1055/s-0038-1675334; Maiwall R, Bajpai M, Singh A, Agarwal T, Kumar G, Bharadwaj A, et al. Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20(4):e831–e854. PMID: 33524593 https://doi.org/10.1016/j.cgh.2021.01.036; Larsen FS, Saliba F. Liver support systems and liver transplantation in acute liver failure. Liver Int. 2025;45(3):e15633. PMID: 37288706 https://doi.org/10.1111/liv.15633; https://www.jtransplantologiya.ru/jour/article/view/1008
-
2Academic Journal
Συγγραφείς: Z. A. Bagateliya, P. A. Drozdov, S. A. Astapovich, E. A. Lidzhieva, F. F. Alieva, A. V. Shabunin, З. А. Багателия, П. А. Дроздов, С. А. Астапович, Э. А. Лиджиева, Ф. Ф. Алиева, А. В. Шабунин
Πηγή: Transplantologiya. The Russian Journal of Transplantation; Том 16, № 4 (2024); 500-506 ; Трансплантология; Том 16, № 4 (2024); 500-506 ; 2542-0909 ; 2074-0506
Θεματικοί όροι: лигирование аневризмы селезеночной артерии, liver cirrhosis, orthotopic liver transplantation, ligation of the splenic artery aneurysm, цирроз печени, ортотопическая трансплантация печени
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/943/910; https://www.jtransplantologiya.ru/jour/article/view/943/914; Panzera F, Inchingolo R, Rizzi M, Biscaglia A, Schievenin MG, Tallarico E, et al. Giant splenic artery aneurysm presenting with massive upper gastrointestinal bleeding: a case report and review of literature. World J Gastroenterol. 2020;26(22):3110–3117. https://doi.org/10.3748/wjg.v26.i22.3110; Batagini NC, Constantin BD, Kirksey L, Vallentsits Estenssoro AE, PuechLeão P, De Luccia N, et al. Natural history of splanchnic artery aneurysms. Ann Vasc Surg. 2021;73:290–295. PMID: 33346122 https://doi.org/10.1016/j.avsg.2020.10.047; Leal J, Batagini NC, Stefan de Faria Oliveira I, Frederico MG, Rodrigues MS, Casella IB, et al. Comparison of splenic artery aneurysms in patients with and without portal hypertension. Ann Vasc Surg. 2024;109:232–237. PMID: 39009114 https://doi.org/10.1016/j.avsg.2024.06.010; Gupta S, Pottakkat B, Verma SK, Kalayarasan R, Chandrasekar AS, Pillai AA. Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hyper tension. World J Gastrointest Surg. 2020;12(1):1–8. PMID: 31984119 doi.org/10.4240/wjgs.v12.i1.1; Phan D, Furtado R, Laurence JM, Pleass H. Splenic artery aneurysm management in the cirrhotic patient listed for liver transplantation: a systematic review. Transplant Proc. 2022;54(3):706– 714. https://doi.org/10.1016/j.transproceed.2022.01.031; Wang S, Huang W, Liu J, Liu Q, Wang Z, Wang Q, et al. Selection of endovascular treatment strategies and analysis of the efficacy of different locations and types of splenic artery aneurysms. CVIR Endovasc. 2024;7(1):16. PMID: 38294662 https://doi.org/10.1186/s42155-024-00427-9; Gong C, Sun MS, Leng R, Ren H-L, Zheng K, Wang S-X, et al. Endovascular embolization of visceral artery aneurysm: a retrospective study. Sci Rep. 2023;13(1):6936. PMID: 37117396 https://doi.org/10.1038/s41598-023-33789-6; Шабунин А.В., Багателия З.А., Бедин В.В., Тавобилов М.М., Карпов А.А., Алиева Ф.Ф. и др. Морфологическое обоснование хирургического лечения пациентов с истинной аневризмой селезеночной артерии. Анналы хирургической гепатологии. 2024;29(3):100–107. https://doi.org/10.16931/1995-5464.2024-3-100107; Sun LM, Chen HJ, Jeng LB, Li TC, Wu SC, Kao CH. Splenectomy and increased subsequent cancer risk: a nationwide population-based cohort study. Am J Surg. 2015;210(2):243– 251. PMID: 25986002 https://doi.org/10.1016/j.amjsurg.2015.01.017; Шабунин А.В., Бедин В.В., Тавобилов М.М., Карпов А.А., Алиева Ф.Ф. Программа лечения больных с истинными аневризмами селезеночной артерии в хирургической клинике Боткинской больницы. Московский хирургический журнал. 2023;(3):81–89. https://doi.org/10.17238/2072-3180-2023-3-81-89; https://www.jtransplantologiya.ru/jour/article/view/943
-
3Academic Journal
Πηγή: Кардиология в Беларуси. :77-91
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, ортотопическая трансплантация печени, orthotopic liver transplantation, ишемическая болезнь сердца, мультифокальный атеросклероз, факторы кардиоваскулярного риска, factors of cardiovascular risk, multifocal atherosclerosis, ischemic heart disease, 3. Good health
-
4Academic Journal
Συγγραφείς: A. V. Shabunin, P. A. Drozdov, O. N. Levina, E. A. Lidzhievа, А. В. Шабунин, П. А. Дроздов, О. Н. Левина, Э. А. Лиджиева
Πηγή: Transplantologiya. The Russian Journal of Transplantation; Том 15, № 3 (2023); 341-346 ; Трансплантология; Том 15, № 3 (2023); 341-346 ; 2542-0909 ; 2074-0506
Θεματικοί όροι: ортотопическая трансплантация печени, hemophilia A, orthotopic liver transplantation, гемофилия А
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/794/800; https://www.jtransplantologiya.ru/jour/article/view/794/808; Marchioro TL, Hougie C, Ragde H, Epstein RB, Thomas ED. Hemophilia: role of organ homografts. Science. 1969;163(3863):188–190. PMID: 4883723 https://doi.org/10.1126/science.163.3863.188; Pradhan-Sundd T, Gudapati S, Kaminski TW, Ragni MV. Exploring the complex role of coagulation factor VIII in chronic liver disease. Cell Mol Gastroenterol Hepatol. 2021;12(3):1061–1072. PMID: 33705963 https://doi.org/10.1016/j.jcmgh.2021.02.014; Arruda VR. The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A. Haematologica. 2015;100(7):849–850. PMID: 26130509 https://doi.org/10.3324/haematol.2015.129858; Wilde JT. HIV and HCV coinfection in haemophilia. Haemophilia. 2004;10(1):1–8. PMID: 14962214 https:// doi.org/10.1046/j.1351-8216.2003.00828.x; Kliegman RM. Nelson textbook of pediatrics. 19th ed. Philadelphia: Saunders Elsevier; 2011.; McCarthy M, Gane E, Pereira S, Tibbs CJ, Heaton N, Rela M, et al. Liver transplantation for haemophiliacs with hepatitis C cirrhosis. Gut. 1996;39(6):870–875. PMID: 9038673 https://doi.org/10.1136/gut.39.6.870; Шабунин А.В., Парфенов И.П., Минина М.Г., Бедин В.В., Дроздов П.А., Левина О.Н. и др. Программа трансплантации печени в Боткинской больнице. Опыт 100 операций. Вестник трансплантологии и искусственных органов. 2022;24(2):23–30.; Yokoyama S, Bartlett A, Dar FS, Heneghan M, O'Grady J, Rela M, et al. Outcome of liver transplantation for haemophilia. HPB (Oxford). 2011;13(1):40–45. PMID: 21159102 https://doi.org/10.1111/j.1477-2574.2010.00237.x; Alonso Madrigal C, Dobón Rebollo M, Laredo de la Torre V, Palomera Bernal L, García Gil FA. Liver transplantation in hemophilia A and von Willebrand disease type 3: perioperative management and post-transplant outcome. Rev Esp Enferm Dig. 2018;110(8):522–526. PMID: 29931985 https://doi.org/10.17235/reed.2018.5204/2017; Ragni MV, Humar A, Stock PG, Blumberg EA, Eghtesad B, Fung JJ, et al. Hemophilia liver transplantation observational study. Liver Transpl. 2017;23(6):762–768. PMID: 27935212 https://doi.org/10.1002/lt.24688; https://www.jtransplantologiya.ru/jour/article/view/794
-
5Academic Journal
-
6Academic Journal
Συγγραφείς: M. L. Katin, A. M. Dzyadz`ko, M. Yu. Gurova, O. O. Rummo, М. Л. Катин, А. М. Дзядзько, М. Ю. Гурова, О. О. Руммо
Πηγή: Transplantologiya. The Russian Journal of Transplantation; Том 11, № 2 (2019); 116-127 ; Трансплантология; Том 11, № 2 (2019); 116-127 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2019-11-2
Θεματικοί όροι: ортотопическая трансплантация печени, orthotopic liver transplantation
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/428/500; https://www.jtransplantologiya.ru/jour/article/view/428/511; Schumann R., Mandell M.S., Mercaldo N. et al. Anesthesiа for liver transplantation in United States academic centers: intraoperative practice. J. Clin. Anesth. 2013;25(7):542–550. PMID:23994704 DOI:10.1016/j.jclinane.2013.04.017; Frezza E.E., Mezghebe H. Indications and complications of arterial catheter use in surgical or medical intensive care units. Analysis of 4932 patients. Am. Surg. 1998;64(2):127–131. PMID:9486883; Dorman T., Breslow M.J., Lipsett P.A., et al. Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients. Crit. Care Med. 1998; 26(10):1646–1649. PMID:9781720 DOI:10.1097/00003246-199810000-00014; Stern D.H., Gerson J.I., Allen F.B., Parker F.B. Can we trust the direct radial artery pressure immediately following cardiopulmonary bypass? Anesthesiology. 1985;62(5):557–561. PMID:3994020 DOI:10.1097/00000542-198505000-00002; Pauca A.L., Hudspeth A.S., Wallenhaupt S.L., et al. Radial artery-to-aorta pressure difference after discontinuation of cardiopulmonary bypass. Anesthesiology. 1989;70(6):935–941. PMID:2729634 DOI:10.1097/00000542-198906000-00009; Dorman T., Breslow M.J., Lipsett P.A., et al. Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients. Crit. Care Med. 1998;26(10):1646–1649. PMID:9781720 DOI:10.1097/00003246-199810000-00014; Acosta F., Sansano T., Beltran R., et al. Is femoral and radial artery pressure different during reperfusion in liver transplantation? Transplant. Proc. 2000;32(8):2647. PMID:11134741 DOI:10.1016/S0041-1345(00)01821-2; Meirelles Júnior R.F., Salvalaggio P., Rezende M.B., et al. Liver transplantation: history, outcomes and perspectives. Einstein (Sao Paulo). 2015;13(1):149–152. PMID:25993082 DOI:10.1590/S1679-45082015RW3164; Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–310. PMID:2868172 10. Albers I., Hartmann H., Bircher J., Creutzfeldt W. Superiority of the ChildPugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand. J. Gastroenterol. 1989;24(3):269–276. PMID:2734585; Remington J.W., Wood E.H. Formation of peripheral pulse contour in man. J. Appl. Physiol. 1956;9(3):433– 442. PMID:13376469 DOI:10.1152/jappl.1956.9.3.433; Manecke G.R. Jr., Parimucha M., Stratmann G., et al. Deep hypothermic circulatory arrest and the femoral-toradial arterial pressure gradient. J. Cardiothorac. Vasc. Anesth. 2004;18(2):175– 179. PMID:15073707; Riley L.E., Chen G.J., Latham H.E. Comparison of noninvasive blood pressure monitoring with invasive arterial pressure monitoring in medical ICU patients with septic shock. Blood Press. Monit. 2017;22(4):202–207. PMID:28379881 DOI:10.1097/MBP.0000000000000258; Kim W.Y., Jun J.H., Huh J.W., et al. Radial to Femoral Arterial Blood Pressure Differences in Septic Shock Patients Receiving High-Dose Norepinephrine Therapy. Shock. 2013;40(6):527–531. DOI:10.1097/SHK.0000000000000064; Rivers E.P., Lozon J., Enriquez E., et al. Simultaneous radial, femoral, and aortic arterial pressures during human cardio-pulmonary resuscitation. Crit. Care Med. 1993;21(6):878–883. PMID:8504656; Fuda G., Denault A., Deschamps A., et al. Risk Factors Involved in Centralto-Radial Arterial Pressure Gradient During Cardiac Surgery. Anesth. Analg. 2016;122(3):624–632. PMID:26599795 DOI:10.1213/ANE.0000000000001096; Arnal D., Garutti I., Perez-Peña J., et al. Radial to femoral arterial blood pressure differences during liver transplantation. Anaesthesia. 2005;60(8):766–771. PMID:16029225 DOI:10.1111/j.1365-2044.2005.04257.x; Shin Y.H., Kim H.Y., Kim Y.R., et al. The comparison of femoral and radial arterial blood pressures during pediatric liver transplantation. Transplant. Proc. 2013;45(5):1924–1927. PMID:23769074 DOI:10.1016/j.transproceed.2012.08.025; Shin B.S., Kim G.S., Ko J.S., et al. Comparison of femoral arterial blood pressure with radial arterial blood pressure and noninvasive upper arm blood pressure in the reperfusion period during liver transplantation. Transplant. Proc. 2007;39(5):1326–1328. PMID:17580132 DOI:10.1016/j.transproceed.2007.02.075; Mohr R., Lavee J., Goor D.A. Inaccuracy of radial artery pressure measurement after cardiac operations. J. Thorac. Cardiovasc. Surg. 1987;94(2):286–290. PMID:3497310; Seto A.H., Abu-Fadel M.S., Sparling J.M., et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC Cardiovasc. Interv. 2010;3(7):751–758. DOI:10.1016/j.jcin.2010.04.015; Sobolev M., Slovut D.P., Lee Chang A., et al. Ultrasound-Guided Catheterization of the Femoral Artery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Invasive Cardiol. 2015;27(7):318–323. PMID:26136279; https://www.jtransplantologiya.ru/jour/article/view/428
-
7Academic Journal
Συγγραφείς: D. O. Efremov, O. A. Gerasimova, K. V. Kozlov, I. A. Gabdrakhmanov, K. V. Zhdanov, Д. О. Ефремов, О. А. Герасимова, К. В. Козлов, И. А. Габдрахманов, К. В. Жданов
Πηγή: Journal Infectology; Том 11, № 4 (2019); 148-152 ; Журнал инфектологии; Том 11, № 4 (2019); 148-152 ; 2072-6732 ; 10.22625/2072-6732-2019-11-4
Θεματικοί όροι: ортотопическая трансплантация печени, cytomegalovirus infection, cytomegalovirus hepatitis, immunosuppressive therapy, orthotopic liver transplantation, цитомегаловирусная инфекция, цитомегаловирусный гепатит, иммуносупрессивная терапия
Περιγραφή αρχείου: application/pdf
Relation: https://journal.niidi.ru/jofin/article/view/974/756; Исаков, В.А. Герпес-вирусные инфекции человека : руководство для врачей / В.А. Исаков, Е.И. Архипова, Д.В. Исаков. - СПб.: СпецЛит, 2006. - 303 с.; Руководство по инфекционным болезням : в 2 кн / Ю.В. Лобзин [и др.] - 4-е изд., доп. и перераб. - СПб.: Фолиант, 2011. - Кн. 2 - 744 с.; Кожевина, Г.И. Цитомегаловирусный мононуклеоз у ребёнка / Г.И. Кожевина [и др.] // Журнал инфектоло-гии. - 2010. - Т. 2, №. 3. - С. 100-101.; Егорова, Н.Ю. Инфекционный мононуклеоз у детей: диагностика, лечение и наблюдение в катамнезе / Н.Ю. Егорова [и др.] // Педиатрия. — 2010. — № 4. — Приложение Consillium medicum. — С. 73 — 79.; Aarnisalo J., Ilonen J., Vainionpaa R., Kaitosaari T., Simell O. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study. Scandinavian Journal of Infectious Diseases. 2003 Jun; 35(10): 750-753.; Arvin A., Campadelli-Fiume G., Mocarski E., Moore P., Roizman B., Whitley R., Yamanishi K. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis: Cambridge University Press; с 2007. 1408 р.; Герпес-вирусная инфекция / А.К. Полукчи [и др.]. — М.: Эксмо, 2009. — 304 с.; Brennan D.C. et al. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy. Journal of the American Society of Nephrology. 1997 Jan; 8(1): 118-125.; Учайкин, В.Ф. Герпесвирусные гепатиты у детей / В.Ф. Учайкин [и др.] // Педиатрия. Журнал им. Г.Н. Сперанского. - 2012. - Т. 91, №. 3. - С. 136-142.; Смирнов, А.В. Клинические варианты течения ци-томегаловирусного гепатита / А.В. Смирнов // Детские инфекции. - 2008. - Т. 7, № 1. - С. 18-23.; Bruminhent J., Razonable R. R. Management of cytomegalovirus infection and disease in liver transplant recipients. World Journal of Hepatology. 2014 Jun; 6(6): 370383.; Прокопенко, Е.И. Вирусные инфекции и трансплантация почки / Е.И. Прокопенко // Нефрология и диализ. -2003. - Т. 5, №. 2. - С. 108-116.; Barkholt L. M., Johansson B., Veress J., Andersson J. P., Ehrnst A. Polymerase chain reaction for the early diagnosis of cytomegalovirus hepatitis in liver transplant patients. Clinical and Diagnostic Virology. 1995 Aug; 4(2): 121-134.; Razonable R. R., Emery V. C. Management of CMV infection and disease in transplant patients. Herpes: The Journal of the IHMF. 2004 Feb; 11(3): 77-86.; Razonable R. R., Paya C. V. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes: The Journal of the IHMF. 2003 Dec; 10(3): 60-65.; Chou S. W. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. The Journal of infectious diseases. 1989 Jul; 160 (1): 5-11.; Sia I. G., Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clinical Microbiology Reviews. 2000 Jan; 13(1): 83-121.; https://journal.niidi.ru/jofin/article/view/974
-
8Academic Journal
Συγγραφείς: A. V. Moiseenko, A. A. Polikarpov, D. A. Granov, P. G. Tarazov, C. V. Shapoval, A. R. Sheraliev, A. G. Karahanova, А. В. Моисеенко, А. А. Поликарпов, Д. А. Гранов, П. Г. Таразов, С. В. Шаповал, А. Р. Шералиев, А. Г. Караханова
Πηγή: Russian Journal of Transplantology and Artificial Organs; Том 20, № 3 (2018); 75-79 ; Вестник трансплантологии и искусственных органов; Том 20, № 3 (2018); 75-79 ; 1995-1191 ; 10.15825/1995-1191-2018-3
Θεματικοί όροι: желтуха, biliary cirrhosis, orthotopic liver transplantation, jaundice, билиарный цирроз, ортотопическая трансплантация печени
Περιγραφή αρχείου: application/pdf
Relation: https://journal.transpl.ru/vtio/article/view/915/734; Гранов АМ, Гранов ДА, Жеребцов ФК, Полысалов ВН, Герасимова ОА и др. Трансплантация печени в РНЦРХТ. Опыт 100 трупных трансплантаций печени в Российском научном центре радиологии и хирургических технологий. Вестник хирургии имени И.И. Грекова. 2012; 171 (2): 74–77. Granov AM, Granov DA, Zherebcov FK, Polysalov VN, Gerasimova OA et al. Experience of 100 liver transplantation in RSCRST. Herald of surgery I.I. Grekov. 2012; 171 (2): 74–77.; Готье СВ. Трансплантация печени: современное состояние проблемы. Альманах института хирургии им. А.В. Вишневского. 2008; 3 (3): 9–17. Gautier SV. Liver transplantation: current state of the problem. Almanac of surgery institute A.V. Vishnevsky. 2008; 3 (3): 9–17.; Готье СВ, Мойсюк ЯГ, Хомяков СМ. Донорство и трансплантация органов в Российской Федерации в 2014 году. VII сообщение регистра Российского трансплантологического общества. Вестник трансплантологии и искусственных органов. 2015; 17 (2): 7–22. Gautier SV, Moysuk YG, Homyakov SM. Organ donation and transplantation in Russian Federation in 2014. 7-th report of National Register. Russian Journal of Transplantology and Artificial Organs. 2015; 17 (2): 7–22.; Затевахин ИИ, Цициашвили МШ, Шиповский ВН и др. Малоинвазивные способы коррекции осложнений синдрома портальной гипертензии. Анналы хирургической гепатологии. 2012; 17 (2): 8–13. Zatevahin II, Ciciashvili MS, Shipovskiy VN et al. Minimally invasive methods for correction complications of portal hypertension syndrome. Annals of surgical hepatology. 2012; 17 (2): 8–13.; She WH, Chan ACY, Cheung TT et al. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels. World J. Hepatol. 2018; 10 (2): 308–318.; Simoes P, Varun K, Ahmad J. Spectrum of biliary complications following live donor liver transplantation. World J. Hepatol. 2015; 7 (14): 1856–1865.; Levicar N, Pai M, Habib NA et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Proliferation. 2008; 41 (1): 115–125.; Unger L, Stork T, Bucsics T et al. The role of TIPS in the management of liver transplant candidates. United Eur. Gastroenterol. J. 2017; 5 (8): 1100–1107.; Garcia-Pagan JC, Caca K, Bureau C et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N. Engl. J. Med. 2010; 362 (25): 2370–2379.; Gines P, Colahora B et al. TIPS versus paracentesis plus albumin for refractory acites in cirrhosis. Gastroenterology. 2002; 123 (6): 1839–1847.; Freise CE, Gillespie BW, Koffron AJ et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am. J. Transplant. 2008; 8 (12): 2569–2579.; Vagefi PA, Parekh J, Ascher NL et al. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch. Surg. 2011; 146 (9): 1052–1059.; Noack K, Bronk SF, Kato A et al. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation. 1993; 56 (3): 495–500.; https://journal.transpl.ru/vtio/article/view/915
-
9Academic Journal
Συγγραφείς: V. E. Syutkin, A. A. Saliyenko, D. E. Syutkina, A. V. Chzhao, В. Е. Сюткин, А. А. Салиенко, Д. Е. Сюткина, А. В. Чжао
Πηγή: Transplantologiya. The Russian Journal of Transplantation; № 3-4 (2010); 18-22 ; Трансплантология; № 3-4 (2010); 18-22 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2010-0-3-4
Θεματικοί όροι: гранулоцитарномакрофагальный колониестимулирующий фактор, HBV, vaccination, liver transplantation, molgramostim, гепатит В, ортотопическая трансплантация печени, молграмостим
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/289/352; Roche B., Samuel D., Gigou M. et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997;26(3):517–26.; Fabia R., Levy M.F., Crippin J. et al. De novo hepatitis B infection after liver transplantation: sources of disease, incidence and impact. Liver Transpl Surg 1998;4(2):119–27.; Su W.J., Ho M.C., Ni Y.H. et al. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. J Pediatr Gastroenterol Nutr 2009;48(2):203–8.; Cholongitas E., Papatheodoridis G.V., Burroughs A.K. Liver grafts from antihepatitis B core positive donors: A systematic review. J of Hepatol 2010;52(2):272–9.; Barcena R., Moraleda G., Moreno J. et al. Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers. World J Gastroenterol 2006;12(13):2070–4.; Roque-Afonso A.M., Feray C., Samuel D. et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 2002;50(1):95–9.; Loinaz C., de Juanes J.R., Gonzales E.M. et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997;44(13): 235–8.; Tarr P.E., Lin R., Mueller E.A. et al. Evaluation of tolerability and antibody response after recombinant human granulocyte colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine. Vaccine 1996;14(13):1199–204.; Hasan M.S., Agosti J.M., Reynolds K.K. et al. Granulocyte macrophage colony stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults. J Infect Dis 1999;180(6):2023–6.; Fabrizi F., Ganesha S.V., Dixit V., Martin P. Meta-analysis: the adjuvant role of granulocyte-macrophage colony-stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther 2006;24(5):789–96.; Sasaki M.G., Foccacia R., de MessiasReason I.J. Efficacy of granulocytemacrophage colony-stimulating factor (GMCSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection. Vaccine 2003;21(31):4545–9.; Martin P., Friedman L.S. Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 1995;47(5): 1231–41.; Cornberg M., Protzer U., Dollinger M.M. et al. Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virus-(HBV-) Infection- “Upgrade” der Leitlinie, AWMF-RegisterNr.:021/011. Z Gastroenterol 2007; 45:525–74.; Cornberg M., Protzer U., Dollinger M.M. et al. The German guideline for the management of hepatitis B virus infection: short version. J Viral Hepatitis 2008; 15(suppl 1):1–20.; Sanchez-Fueyo A., Rimola A., Grande L. et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000; 31(2):496–501.; Angelico M., Di Paolo D., Trinito M.O. et al. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology 2002;35(1):176–81.; Di Paolo D., Lenci I., Trinito M.O. et al. Extended double-dosage HBV vaccination after liver transplantation is ineffective in the absence of lamivudine and prior wash-out of human hepatitis B immunoglobulins. Dig Liver Dis 2006;38(10):749–54.; Karasu Z., Ozacar T., Akarca U. et al. HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence. J Viral Hepat 2005;12(2):212–5.; Yamashiki N., Sugawara Y., Tamura S. et al. Double-dose double-phase use of second generation hepatitis B virus vaccine in patients after living donor liver transplantation: Not an effective measure in transplant recipients. Hepatol Res 2009;39(1):7–13.; Rosenau J., Hooman N., Hadem J. et al. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl 2007;13(3):367–73.; Merli M., Nicolini G., Attili F.A. et al. Failure of hepatitis B vaccination to induce either humoral or cellular immune response after liver transplantation for hepatitis B related cirrhosis. J Hepatol 2005; 43(6):1089–90.; Soejima Y., Ikegami T., Taketomi A. et al. Hepatitis B vaccination after living donor liver transplantation. Liver Int 2007;27(7):977–82.; Park J.B., Kwon C.H., Lee K.W. et al. Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients. Transpl Int 2008;21(4):346–52.; Kwon C.H., Suh K.S., Yi N.J. et al. Longterm protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation. Pediatr Transplant 2006;10(4):479–86.; McMahon B.J., Parkinson A.J., Helminiak C. et al. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology 1992;103(2):590–4.; Lo C.M., Lau G.K., Chan S.C. et al. Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. Am J Transplant 2007;7(2):434–9.; Bienzle U., Gunther M., Neuhaus R. et al. ful hepatitis B vaccination in patients who underwent transplantation for hepatitis B virus-related cirrhosis: preliminary results. Liver Transpl 2002;8(6):562–4.; Starkel P., Stoffel M., Lerut J. et al. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBVinfected liver graft recipients. Liver Transpl 2005;11(10):1228–34.; Vandepapeliere P., Lau G.K., LerouxRoels G. et al. Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of coadministration of HBsAg/AS02 candidate vaccine and lamivudine. Vaccine 2007;25(suppl 1):8585–97.; Bienzle U., Gunther M., Neuhaus R. et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003;38(4):811–9.; Bauer T., Gunther M., Bienzle U. et al. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAgspecific regulatory T cells. Liver Transpl 2007;13(3):434–42.; https://www.jtransplantologiya.ru/jour/article/view/289
-
10Academic Journal
Συγγραφείς: O. O. Rummo, A. M. Dzyadzko, A. M. Fedoruk, A. E. Shcherba, A. F. Minov, О. О. Руммо, А. М. Дзядзько, А. М. Федорук, А. Е. Щерба, А. Ф. Минов
Πηγή: Transplantologiya. The Russian Journal of Transplantation; № 1 (2010); 68-71 ; Трансплантология; № 1 (2010); 68-71 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2010-0-1
Θεματικοί όροι: ортотопическая трансплантация печени, orthotopic liver transplantation
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/273/336; Статистические данные Министерства здравоохранения Республики Беларусь. http:// minzdrav.by/med/article/statsod.php?prg=13; Busuttil R., Klintmalm G. Transplantation of the liver. 2nd ed. Philadelphia: Elsevier Saunders, 2005.; Starzl T.E., Groth C.G., Brettschneider L. et al. Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery 1968;63(4):549–63.; OPTN/SRTR annual report. http://optn. transplant.hrsa.gov/ar2008/waitlist_outcomes.htm; Schrem H., Till N., Becker T. et al. Longterm results after liver transplantation. Chirurg 2008;79(2):121–9.; https://www.jtransplantologiya.ru/jour/article/view/273
-
11Academic Journal
Συγγραφείς: Yu. V. Skvortsova, O. D. Olisov, V. E. Syutkin, D. M. Konovalov, A. V. Chzhao, Ю. В. Скворцова, О. Д. Олисов, В. Е. Сюткин, Д. М. Коновалов, А. В. Чжао
Πηγή: Transplantologiya. The Russian Journal of Transplantation; № 1 (2010); 61-67 ; Трансплантология; № 1 (2010); 61-67 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2010-0-1
Θεματικοί όροι: реакция «трансплантат против хозяина», orthotopic liver transplantation, graft-versus-host reaction, ортотопическая трансплантация печени
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/272/335; Taylor A.T., Gibbs P., Bradley J.A. Acute graft versus host disease following liver transplantation: the enemy within. Am J Transpl 2004;4:466–74.; Burdick J.F., Vogelsang G.B., Smith W.J. et al. Severe graft-versus-host disease in liver-transplant recipient. N Engl J Med 1988;318:689–91.; Perri R., Assi M., Talwalkar J. et al. Graft versus host disease after liver transplantation: a new approach is needed. Liver Transpl 2007;13:1092–9.; Taylor A.L., Gibbs P., Key T. et al. Monitoring systemic donor lymphocyte macrochimerism to aid the differential diagnosis of Graft versus host disease following liver transplantation. Transplantation 2004;77:441–6.; Smith D.M., Agura E., Netto G. et al. Liver transplant-associated graft-versus-host disease. Transplantation 2003;75:118–26.; Au W.Y., Lo C.M., Hawkins B.R. et al. Evan’s syndrome complicating chronic graft versus host disease after cadaveric liver transplantation. Transplantation 2001;72:527–8.; Nemoto T., Kubota K., Kita J. et al. Unusual onset of chronic graft-versus-host disease after adult living-related liver transplantation from a homozygous donor. Transplantation 2003;75:733–6.; Whitington P.F., Alonso E.M., Piper J.B. et al. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from a HLAhomozygous parental living donor. Transplantation 1996;62:1516–9.; Apperley J., Gluckman E., Grawohl A. Blood and Marrow Transplantation, European School of Haematology, EBMT, 1998.; Collins R.H., Anastasi J., Tertappen L.W. et al. Brief-report: donor-derived long-term multilineage hematopoiesis in a liver transplant recipient. N Engl J Med 1993;328:762–5.; Peters C., Minkov M., Gadner H. et al. Statement of current majority practices in graff-vwrsus-host disease prophylaxis and treatment in children. Bone marrow transplant 2000;26:405–11.; Massenkeil G., Rackwitz S., Genvresse I. et al. Basiliximab is well torerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Bone marrow transplant 2002;30:899–903.; Lee S.J., Vogelsang G., Gilman A. et al. A survey of diagnosis, vanagement, and grading of chronic GVHD. Biol Blood and Marrow Transplant 2002;8:32–9.; Saroglia E.M., Lanino E., Manfredini L. et al. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in cildren recciving bone marrow transplantation. Bone marrow transplant 2000;25:1067–71.; https://www.jtransplantologiya.ru/jour/article/view/272
-
12Academic Journal
Συγγραφείς: E. A. Kiseliova, E. F. Kim, I. A. Ushakova, G. P. Matveev, A. V. Vabishchevich, Е. А. Киселева, Э. Ф. Ким, И. А. Ушакова, Г. П. Матвеев, А. В. Вабищевич
Πηγή: Transplantologiya. The Russian Journal of Transplantation; № 1-2 (2012); 38-42 ; Трансплантология; № 1-2 (2012); 38-42 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2012-0-1-2
Θεματικοί όροι: функция трансплантата, orthotopic liver transplantation, graft function, ортотопическая трансплантация печени
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/377/437; Анестезиологическое обеспечение трансплантации печени / А.В. Вабищевич [и др.] // Анестезиология и реаниматология. – 2002. – № 5. – С. 42–49.; Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver / S. Aggarwal [et al.] // J. Crit. Care. – 1993. – 17. – P. 154–160.; Postreperfusion syndrome: Cardiovascular collapse following hepatic reperfusion during liver transplantation / S. Aggarwal [et al.] // Transplant. Proc. – 1987. – 19, Suppl. 3. – P. 54–55.; Double blind randomized controlled trial on the effects of mannitol on the postreperfusion syndrome during orthotopic liver transplantations / G. Dembo [et al.] // International J. Anaesthesia. – 2006. – 6. – P. 1–13.; The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation / I. Hilmi [et al.] // Liver Transplant. – 2008. – 14. – P. 504–508.; Post-reperfusion Syndrome and Outcome Variables after Orthotopic Liver Transplantation / M.B. Khosravi [et al.] // Int. J. Org. Transplant. Med. – 2010. – Vol. 1 (3). – P. 115–120.; The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation / H. Koelzow [et al.] // Anesth. Analg. – 2002. – 94. – P. 824–829.; Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center / A. Nanashima [et al.] // J. Hepatobiliary. Pancreat. Surg. – 2001. – 8 (6). – P. 557–563.; Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors / C. Paugam-Burtz [et al.] // Liver Transpl. – 2009. – May, 15 (5). – P. 522–529.; Mannitol dose-dependently attenuates lung reperfusion injury following liver ischemia reperfusion: a doseresponse study in an isolated perfused double-organ model / A.A. Weinbroum [et al.] // Lung. – 2002. – 180. – P. 327– 338.; Cholestatic jaundice after hepatic transplantation: a nonimmunologically mediated event / J.W. Williams [et al.] // Am. J. Surg. – 1986. – 151. – P. 65–70.; https://www.jtransplantologiya.ru/jour/article/view/377
-
13Academic Journal
Συγγραφείς: P. G. Tarazov, D. A. Granov, A. A. Polikarpov, M. I. Generalov, I. O. Rutkin, O. A. Gerasimova, F. K. Zherebtsov, П. Г. Таразов, Д. А. Гранов, А. А. Поликарпов, М. И. Генералов, И. О. Руткин, О. А. Герасимова, Ф. К. Жеребцов
Πηγή: Transplantologiya. The Russian Journal of Transplantation; № 1 (2009); 38-43 ; Трансплантология; № 1 (2009); 38-43 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2009-0-1
Θεματικοί όροι: ортотопическая трансплантация печени, intervention radiology, hepatic cirrhosis, portal hypertension, orthotopic liver transplantation, интервенционная радиология, цирроз печени, портальная гипертензия
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/238/300; Rösch J., Hanafee W.N., Snow H. Transjugular portal venography and radiologic portacaval shunt: An experimental study. Radiology 1969;92:1112—4.; Colapinto R.F., Stronell R.D., Birch S.J. et al. Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. Can Med Assoc J 1982;126:267—8.; Rössle M., Richter G.M., Nöldge G. et al. Performance of an intrahepatic portacaval shunt (PCS) using a catheter technique: A case report. Hepatology 1988;8:1348.; Barton R.E., Rösch J., Saxon R.R. et al. TIPS, short and long-term results: A survey of 1750 patients. Semin Intervent Radiol 1995;12:364—6.; Ferguson J.W., Hayes P.C. Transjugular intrahepatic portosustemic shunt in the prevention of rebleeding in oesophageal varices. Eur J Gastroenterol Hepatol 2006;18: 1167—71.; Senzolo M., Cholangitas E., Tibbals J. et al. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome. Eur J Gastroenterol Hepatol 2006;18:1143—50.; Chui A.K.K., Rao A.R.N., Waugh R.C. et al. Liver transplantation in patients with transjugalar intrahepatic portosystemic shunts. Aust NZ J Surg 2000;70:493—5.; Hidajat N., Vogl T., Stobbe H. et al. Transjugular intrahepatic portosystemic shunt: Experiences at a liver transplantation center. Acta Radiologica 2000;41:474—8.; Ong J.P., Sands M., Younossi Z.M. Transjugular intrahepatic portosystemic shunts (TIPS): A decade later. J Clin Gastroenterol 2000;30:14—28.; Рыжков В.К., Карев А.В., Борисов А.Е., Петрова С.Н. Внутрипеченочный портокавальный шунт в лечении портальной гипертензии при циррозе печени. Вестн хирургии 2007;166(4):11—5.; Шиповский В.Н., Цициашвили М.Ш., Хуан Ч. и др. Эндоваскулярные способы коррекции при синдроме портальной гипертензии. Материалы 8-й НПК «Актуальные вопросы интервенционной радиологии (рентгенохирургии)». Владикавказ, 2008. с. 46—9.; Карев А.В., Рыжков В.К., Петрова С.Н., Борисов А.Е. Новый стент из мононити нитинола в создании чрескожного чреспеченочного портосистемного соустья. Вестн рентгенологии 2003;(5):40—2.; Таразов П.Г. Чрезъяремный внутрипеченочный портокавальный анастомоз при лечении портальной гипертензии (обзор литературы). Хирургия 1999;(7):64—9.; Freedman A.M., Sanyal A.J. Complications of transjugular intrahepatic portosystemic shunts. Semin Intervent Radiol 1994;11:161—77.; Sauer P., Theilmann L. Prevention of transjugular intrahepatic portosystemic stent shunt thrombosis. Digestion 1998;59(suppl 2):45—7.; Rosado B., Kamath P.S. Transjugular intrahepatic portosystemic shunts: An update. Liver Transpl 2003;9:207—17.; Rösch J., Keller F.S. Transjugular intrahepatic portosystemic shunt: Present status, comparison with endoscopic therapy and shunt surgery, and future perspectives. World J Surg 2001;25:337—45.; Henderson J.M., Boyer T.D., Kutner M.H. et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: A randomized trial. Gastroenterology 2006;130:1643—51.; Khaitiyar J.S., Luthra S.K., Prasad N. et al. Transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt — a comparative study. Hepatogastroenterology 2000;47:492—7.; Kochar N., Tripathi D., Ireland H. et al. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut 2006;55:1617—23.; Madoff D.C., Wallace M.J., Ahrar K., Saxon R.R. TIPS-related hepatic encephalopathy: Management options with novel endovascular techniques. Radiographics 2004;24:21—36.; Gülberg V., Schepke M., Geigenberger G. et al. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: A randomized, controlled trial. Scand J Gastroenterol 2002;37:338—43.; Lo G.H., Liang H.L., Chen M.H. et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007;39:679—85.; Jalan R., Breizi K.I., Tripathi D. et al. Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: A single-centre study over an 11-year period. Eur J Gastroenterol Hepatol 2002;14:615—26.; McAvoy N.C., Hayes P.C. The use of transjugular intrahepatic portosystemic stent shunt in the management of acute oesophageal variceal haemorrhage. Eur J Gastroenterol Hepatol 2006;18:1135—41.; Zheng M., Chen Y., Bai J. et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: Meta-analysis update. J Clin Gastroenterol 2008;42:507—16.; https://www.jtransplantologiya.ru/jour/article/view/238
-
14Academic Journal
Συγγραφείς: Kiselev N.M., Gorokhov G.G., Belskiy V.A., Bobrov N.A., Mukhanzaev S.K., Zagainov V.E.
Πηγή: Almanac of Clinical Medicine; Vol 46, No 6 (2018); 609-617 ; Альманах клинической медицины; Vol 46, No 6 (2018); 609-617 ; 2587-9294 ; 2072-0505 ; 10.18786/2072-0505-2018-46-6
Θεματικοί όροι: alveococcosis, liver alveococcosis, classification of alveococcosis, liver resection, orthotopic liver transplantation, auto-transplantation, hemihepatectomy, Pichlmayr operation, bile leakage, anti-parasitic therapy, альвеококкоз, альвеококкоз печени, классификация альвеококкоза, резекции печени, ортотопическая трансплантация печени, аутотрансплантация, гемигепатэктомия, операция Пихельмайера, желчеистечение, противопаразитарная терапия
Περιγραφή αρχείου: application/pdf
Relation: https://almclinmed.ru/jour/article/view/900/906; https://almclinmed.ru/jour/article/downloadSuppFile/900/523; https://almclinmed.ru/jour/article/downloadSuppFile/900/524; https://almclinmed.ru/jour/article/downloadSuppFile/900/525; https://almclinmed.ru/jour/article/downloadSuppFile/900/526; https://almclinmed.ru/jour/article/downloadSuppFile/900/527; https://almclinmed.ru/jour/article/downloadSuppFile/900/528; https://almclinmed.ru/jour/article/downloadSuppFile/900/529; https://almclinmed.ru/jour/article/downloadSuppFile/900/530; https://almclinmed.ru/jour/article/downloadSuppFile/900/531; https://almclinmed.ru/jour/article/downloadSuppFile/900/532; https://almclinmed.ru/jour/article/downloadSuppFile/900/533; https://almclinmed.ru/jour/article/view/900
-
15Academic Journal
Συγγραφείς: R. R. Nagimullin, F. A. Shipulin, A. Zh. Bayalieva
Πηγή: Креативная хирургия и онкология, Vol 8, Iss 1, Pp 76-83 (2018)
Θεματικοί όροι: «псевдогепаторенальный» синдромом, системная вазодилатация, вазоконстрикторы, экстракорпоральный альбуминовый диализ, ортотопическая трансплантация печени, шунтирование, Surgery, RD1-811, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Relation: https://www.surgonco.ru/jour/article/view/304; https://doaj.org/toc/2307-0501; https://doaj.org/toc/2076-3093; https://doaj.org/article/ebb1c1b8a5c14ae192622fc58196dbbc
-
16Academic Journal
Συγγραφείς: I A PRONChENKO, I P Ermakova, Ya G Moysyuk, V P Buzulina
Πηγή: Остеопороз и остеопатии, Vol 16, Iss 2, Pp 3-8 (2013)
Θεματικοί όροι: Osteopathy, ортотопическая трансплантация печени, Аллотрансплантации трупной почки, минеральная плотность кости, RZ301-397.5, биохимические маркеры костного обмена, женщины в постменопаузе, 3. Good health
-
17Academic Journal
Συγγραφείς: V P Buzulina, I A Pronchenko, I P Ermakova, N P Shmerko, A A Andrianova, M N Kornilov, E B Yaroshenko, T K Koliashvili
Πηγή: Остеопороз и остеопатии, Vol 16, Iss 1, Pp 18-23 (2013)
Θεματικοί όροι: Osteopathy, 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, ортотопическая трансплантация печени, маркёры костной резорбции, RZ301-397.5, остеопороз
Σύνδεσμος πρόσβασης: https://doaj.org/article/7061762f26954b3bbedf3291d3b7fb5f
https://cyberleninka.ru/article/n/biohimicheskie-markery-rezorbtsii-kosti-regulyatsiya-osteoklastogeneza-i-kostnyh-poter-posle-peresadki-pecheni/pdf
https://endojournals.ru/index.php/osteo/article/view/8844
https://www.osteo-endojournals.ru/jour/article/download/8844/6470
https://cyberleninka.ru/article/n/biohimicheskie-markery-rezorbtsii-kosti-regulyatsiya-osteoklastogeneza-i-kostnyh-poter-posle-peresadki-pecheni
https://paperity.org/p/242085880/biochemical-markers-of-bone-resorption-regulation-of-osteoclastogenesis-and-bone-loss
https://www.osteo-endojournals.ru/jour/article/view/8844 -
18Academic Journal
Συγγραφείς: ШАРИПОВ Ш.З., ЩЕРБА А.Е., ПИКИРЕНЯ И.И., ГЛИННИК А.А., ФЕДОРУК А.М., КОРОТКОВ С.В., РУММО О.О.
Περιγραφή αρχείου: text/html
-
19Academic Journal
Συγγραφείς: I P Ermakova, Ya G Moysyuk, V P Buzulina, T K Koliashvili, E B Yaroshenko, M N Kornilov, I A Pronchenko, N P Shmerko
Πηγή: Остеопороз и остеопатии, Vol 12, Iss 2, Pp 2-4 (2009)
Θεματικοί όροι: ортотопическая трансплантация печени, минеральная плотность костной ткани, первичный билиарный цирроз, хронические вирусные гепатиты, Osteopathy, RZ301-397.5
Περιγραφή αρχείου: electronic resource
Relation: https://endojournals.ru/index.php/osteo/article/view/4100; https://doaj.org/toc/2072-2680; https://doaj.org/toc/2311-0716
Σύνδεσμος πρόσβασης: https://doaj.org/article/12b19abaf9d747bcb7c92f518afdaee6
-
20Academic Journal
Συγγραφείς: V.P. Buzulina, I.A. Pronchenko, I.P. Yermakova, M.N. Kornilov, E.B. Yaroshenko, D.S. Mnatsakanyan, T.K. Koliashvili, N.P. Shmerko, В.П. Бузулина, И.А. Пронченко, И.П. Ермакова, М.Н. Корнилов, Е.Б. Ярошенко, Д.С. Мнацаканян, Т.К. Колиашвили, Н.П. Шмерко
Πηγή: Russian Journal of Transplantology and Artificial Organs; Том 14, № 1 (2012); 19-26 ; Вестник трансплантологии и искусственных органов; Том 14, № 1 (2012); 19-26 ; 1995-1191 ; 10.15825/1995-1191-2012-1
Θεματικοί όροι: ортотопическая трансплантация печени, биохимические маркеры формирования кости, минеральная плотность костной ткани
Περιγραφή αρχείου: application/pdf
Relation: https://journal.transpl.ru/vtio/article/view/108/51; Еpмакова И.П., Пpонченко И.А. Биохимические маркеры костного обмена. Биохимические, аналитические и клинические аспекты использования: Руководство по остеопорозу. М.: Бином. Лаборатория знаний, 2003. С. 168–181.; Ермакова И.П., Пронченко И.А. Современные биохимические маркеры в диагностике остеопороза // Остеопороз и остеопатии. 1998. No 1. С. 24–26.; Люндуп А.В., Онищенко Н.А., Крашенинников М.Е., Шагидулин М.Ю. О роли синусоидальных клеток печени и клеток костного мозга в обеспечении регенераторной стратегии здоровой и поврежденной печени // Вестник трансплантол. и искусств. органов. 2010. No 1. С. 78–85.; Crosbie O.M., Freaney R., McKenna M.J. et al. Predicting bone loss following orthotopic liver transplantation // Gut. 1999. Vol. 44. P. 430–434.; Crosbie O.M., Freaney R., McKenna M.J. et al. Bone density, vitamin D status and disordered bone remodeling in end-stage chronic liver disease // Calcif. Tissue Intern. 1999. Vol. 64. P. 295–300.; Giannini S., Nobile M., Ciuffreda M. et al. Long-term persistence of low bone density in orthotopic liver transplantation // Osteoporos Int. 2000. Vol. 11. P. 417–424.; Guanabens N., Pares A., Alvarez L. et al. Collagen- related marcers of bone turnover reflect the severity liver; fibrosis in patients with primary biliary cirrhosis // J. Bone Miner Res. 1998. Vol. 13. P. 731–738.; Monegal A., Navasa M., Guanabens N. et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for liver transplantation // Calcif. Tissue Intern. 1997. Vol. 60 P. 148–154.; Pajala A., Melkko J., Leppilahti J. et al. Tenascin-C and type 1 and 111 collagen expression in total Achilles tendon rupture. An immunohistochemical study // Histol. Histopathol. 2009. Vol. 24. P. 1207–1211.; Rabinovitz M., Shapiro J., Lian J. еt al. Vitamin D and osteocalcin levels in liver transplantant recipients: is osteocalcin a reliable marcer of bone turnover in such cases? // J. of Hepatology. 1992. Vol. 16. P. 50–55.; Trinchet J-C., Hartmann D.J., Paterson D. et al. Serum type 1 collagen and N-terminal peptide 111 procollagen in patients with alcoholic liver disease: relationship to liver histology // Alcoholism: Clinical and experimental research. 1992. Vol. 15. P. 342–346.; Viedal S.S., Vassiliadis E., Bay-Jensen A.C. et al. Procollagen type 1N-terminal propeptide (P1NP) is a marcer for fibrogenesis in bile duct ligation-induced fibrosis in rats // Fibrogenesis&Tissue Repair. 2010. Vol. 3. P. 5–12.; https://journal.transpl.ru/vtio/article/view/108
